These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7784962)

  • 21. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.
    Dryden C; Young D; Hepburn M; Mactier H
    BJOG; 2009 Apr; 116(5):665-71. PubMed ID: 19220239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cocaine: how dangerous is it during pregnancy?
    Buehler BA
    Nebr Med J; 1995 May; 80(5):116-7. PubMed ID: 7791943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurological correlates of fetal cocaine exposure.
    Chiriboga CA
    Ann N Y Acad Sci; 1998 Jun; 846():109-25. PubMed ID: 9668401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of intrauterine exposure to phencyclidine (PCP) and cocaine on neonates.
    Rahbar F; Fomufod A; White D; Westney LS
    J Natl Med Assoc; 1993 May; 85(5):349-52. PubMed ID: 8496988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perinatal toxicology screening: comparison of various maternal and neonatal samples.
    Kim E; Brion LP; Meenan G; Lehrer M; Suresh BR
    J Perinatol; 1998; 18(2):116-21. PubMed ID: 9605301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MK-801 administration during ethanol withdrawal in neonatal rat pups attenuates ethanol-induced behavioral deficits.
    Thomas JD; Weinert SP; Sharif S; Riley EP
    Alcohol Clin Exp Res; 1997 Oct; 21(7):1218-25. PubMed ID: 9347082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the effects of developmental toxicants: pharmacological and stress vulnerability of offspring.
    Spear LP
    NIDA Res Monogr; 1996; 164():125-45. PubMed ID: 8809870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrauterine cocaine exposure and the risk for sudden infant death syndrome: a meta-analysis.
    Fares I; McCulloch KM; Raju TN
    J Perinatol; 1997; 17(3):179-82. PubMed ID: 9210070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fetal alcohol and drug effects.
    Chiriboga CA
    Neurologist; 2003 Nov; 9(6):267-79. PubMed ID: 14629781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of morphine and cocaine on breathing control in neonatal animals: a minireview.
    Olsen GD; Murphey LJ
    NIDA Res Monogr; 1995; 158():22-39. PubMed ID: 8594487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cocaine addiction as a neurological disorder: implications for treatment.
    Majewska MD
    NIDA Res Monogr; 1996; 163():1-26. PubMed ID: 8809851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perinatal substance abuse: assessment and management of the pregnant woman and her children.
    Redding BA; Selleck CS
    Nurse Pract Forum; 1993 Dec; 4(4):216-23. PubMed ID: 8298340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic handling techniques for the infant affected by cocaine.
    Huffman DM; Price BK; Langel L
    Neonatal Netw; 1994 Aug; 13(5):9-13. PubMed ID: 7854274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?].
    Bläser A; Pulzer F; Knüpfer M; Robel-Tillig E; Vogtmann C; Nickel P; Kiess W
    Klin Padiatr; 2008; 220(5):308-15. PubMed ID: 18260044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The long-term effects of cocaine use during pregnancy--reasons for hope.
    Kane DJ; Aronson RA; Zotti ME
    Wis Med J; 1997 Feb; 96(2):37-40. PubMed ID: 9046233
    [No Abstract]   [Full Text] [Related]  

  • 36. [Neonatal abstinence syndrome: current and future aspects].
    Blondel S; Lefebvre P; Tondeur M; Blum D
    Rev Med Brux; 1993 Mar; 14(3):73-7. PubMed ID: 8475342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.
    Convertino I; Sansone AC; Marino A; Galiulo MT; Mantarro S; Antonioli L; Fornai M; Blandizzi C; Tuccori M
    Drug Saf; 2016 Oct; 39(10):903-24. PubMed ID: 27289228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neonatal withdrawal syndrome: associated drugs and pharmacologic management.
    Levy M; Spino M
    Pharmacotherapy; 1993; 13(3):202-11. PubMed ID: 8321734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prominence of withdrawal symptoms in polydrug-exposed infants.
    D'Apolito K; Hepworth JT
    J Perinat Neonatal Nurs; 2001 Mar; 14(4):46-60. PubMed ID: 11930522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infants at risk: a time for action.
    Nolan EJ
    Pediatr Nurs; 1991; 17(2):175-8. PubMed ID: 1852502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.